Company: HURA
Filing Date: 2025-09-18
Form Type: S-1/A
Source: 0001193125-25-207395
Chunk: 3

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-09-18
Form: S-1/A
Chunk 3
---
 136 |
| PRINCIPAL STOCKHOLDERS                                                                |     | 139 |
| DESCRIPTION OF CAPITAL STOCK                                                          |     | 141 |
| SELLING STOCKHOLDERS                                                                  |     | 144 |
| PLAN OF DISTRIBUTION                                                                  |     | 152 |
| LEGAL MATTERS                                                                         |     | 155 |
| EXPERTS                                                                               |     | 155 |
| WHERE YOU CAN FIND MORE INFORMATION                                                   |     | 156 |
| INDEX TO FINANCIAL STATEMENTS                                                         |     | F-1 |

Please read this prospectus carefully. It describes our business, financial condition, results of operations and prospects, among other things. We are responsible for the information contained in this prospectus and in any free-writing prospectus we have authorized. Neither we nor the underwriters have authorized anyone to provide you with different information, and neither we nor the underwriters take responsibility for any other information others may give you. Neither we nor the underwriters are making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. The information contained in this prospectus is accurate only as of the date on the front of this prospectus, regardless of the time of delivery of this prospectus or any sale of securities. You should not assume that the information contained in this prospectus is accurate as of any date other than its date. i

### ABOUT THIS PROSPECTUS
Unless the context otherwise requires, references in this prospectus to “Company,” “TuHURA,” “we,” “us,” “our,” and “ours” refer to TuHURA Biosciences, Inc., and its subsidiaries where the context so requires.

This prospectus relates to the resale from time to time by the selling stockholders named in this prospectus of up to 9,321,545 shares of common stock. The exhibits to the registration statement of which this prospectus is a part contain the full text of certain contracts and other important documents that we have summarized in this prospectus. Since these summaries may not contain all the information that you may find important in deciding whether to acquire or purchase common stock offered by this prospectus, you should review the full text of these documents. The registration statement and the exhibits and other documents can be obtained from the SEC as indicated under the section entitled “Where You Can Find More Information.”

This prospectus only provides you with a general description of the common stock that the selling stockholders may offer, which is not meant to be a complete description of the